Search

Your search keyword '"Novartis AG -- Forecasts and trends"' showing total 938 results

Search Constraints

Start Over You searched for: Descriptor "Novartis AG -- Forecasts and trends" Remove constraint Descriptor: "Novartis AG -- Forecasts and trends" Topic news, opinion and commentary Remove constraint Topic: news, opinion and commentary
938 results on '"Novartis AG -- Forecasts and trends"'

Search Results

1. T-cell Malignancies Market Dynamics: Key Insights on Acute Lymphocytic Leukemia, Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma, Anaplastic Large Cell Lymphoma, and Adult T-cell Leukemia/Lymphoma | DelveInsight

2. Sarcoma Drugs Strategic Industry Research Report 2023-2024 & 2030, Competitive Profiles of 42 Players Including Amgen, Bayer, Eisai, Eli Lilly, Johnson and Johnson, Novartis, Pfizer Inc

3. Lupus Nephritis Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 30+ Companies Working in the Domain

4. Celiac Disease Pipeline Grows as 25+ Key Pharma Companies Join the Fight for Innovative Treatments | DelveInsight

5. Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight

6. Alzheimer's Drugs Market Report 2024, with Profiles of 10+ Companies Including AbbVie, Biogen, Daiichi Sankyo, Eisai, Eli Lilly, H. Lundbeck, Lupin, Merck, Novartis, Pfizer, Teva Pharmaceutical & More

7. CDK4/6 Inhibitors Market to Grow at Healthy Growth Rate by 2034 Owing to Expanded Usage of Approved Blockbuster CDK4/6 Inhibitors in Early-stage Breast Cancer and the Emergence of Newer Players in Other Indications | DelveInsight

8. Chronic Urticaria Competitive Landscape Assessment 2024: Regeneron|Sanofi (Dupixent) and Genentech|Novartis (Xolair) Dominate the Market

9. Global Prostate Cancer Diagnostics Market to Observe Stunning Growth at a CAGR of ~12% by 2030 | DelveInsight

10. Autoinjectors Market to Grow by USD 303.7 Billion (2024-2028) Driven by Rising Allergies and Need for Immediate Care- Technavio

11. Global Cancer Monoclonal Antibodies Market to Cross ~USD 157 Billion Mark by 2030 | DelveInsight

12. Global Chemotherapy Drugs Market to Grow Substantially at a CAGR of ~9% by 2030 | DelveInsight

13. BCMA-Targeted Therapies Market to Witness Upsurge in Growth During the Study Period (2020-2034) | DelveInsight

14. Rare Kidney Diseases Market Report 2024 to 2035, by Target Indications, Type of Molecule, Route of Administration and Key Geographies

15. Radioligand Therapies Market to Show Immense Growth by 2034, Predicts DelveInsight | Key Companies - Curium US, Eli Lilly, Point Biopharma, Fusion, Astrazeneca

16. Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market size is set to grow by USD 2.24 billion from 2024-2028, Growing geriatric population boost the market, Technavio

17. U.S. Inflammatory Bowel Disease Treatment Market Trends Analysis Report 2024-2030 Featuring Biogen, Novartis, Eli Lilly & Co, UCB, Celltrion, Merck & Co, and Johnson & Johnson

18. Global Advanced Drug Delivery Systems Market Analysis and Technologies Report 2024-2028 with Johnson & Johnson, Novartis, Roche, Pfizer, Merck & Co., Medtronic and Abbott Dominating

19. Cell Therapy Market size is set to grow by USD 31041.49 million from 2023-2027, limitations in traditional organ transplantations fueling demand for cell therapies to boost the market growth, Technavio

20. Cell and Gene Therapies in CNS Disorders Research Report 2024: Pricing and Reimbursement Assessment, Current Treatment Options, Likelihood of Approval and Phase, Future Sales - Forecasts to 2029

21. Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034 | DelveInsight

22. CAR T-Cell Therapy for Non-Hodgkin's Lymphoma Market to Showcase Significant Growth at a CAGR of 15% by 2032 | DelveInsight

23. Global Carglumic Acid Market Report 2024, with Profiles of Top Market Players Including Recordati, Lucane Pharma, Sigma-Aldrich, Novartis, USP, Aceto, AlliChem, TCI America and Tokyo Chemical Industry

24. Global Carglumic Acid Market Report 2024, with Profiles of Top Market Players Including Recordati, Lucane Pharma, Sigma-Aldrich, Novartis, USP, Aceto, AlliChem, TCI America and Tokyo Chemical Industry

25. Beyond the Magnificent 7, These European Giants Fly Under the Radar

26. MarketDigits recently conducted a study predicting that the cytomegalovirus (CMV) treatment market is expected to achieve a value of USD 375 million by the year 2030. The market is anticipated to exhibit a compound annual growth rate (CAGR) of 6.4% throughout the forecast period from 2023 to 2030

27. Global Somatostatin Analogs Market Report 2024-2030 Featuring Major Players - Novartis, Sun Pharma, Midatech Pharma, Ipsen Pharma, Chiasma, Peptron, Dauntless Pharma, Camurus, Teva, and Pfizer

28. Global Somatostatin Analogs Market Report 2024-2030 Featuring Major Players - Novartis, Sun Pharma, Midatech Pharma, Ipsen Pharma, Chiasma, Peptron, Dauntless Pharma, Camurus, Teva, and Pfizer

29. Biologic Therapeutic Drugs: Technologies and Global Market Report 2024, with Company Profiles of Amgen, Abbive, Eli Lilly, Novartis and Glaxosmithkline

30. CAR T-Cell Therapy Market to Register Stunning Growth During the Study Period (2019-2032) | DelveInsight

31. Antimicrobial Therapeutics Market to grow by USD 51.4 billion from 2022 to 2027, North America accounts for 38% of market growth- Technavio

32. Sjogren's Syndrome Market to Register Sustainable Growth During the Study Period (2019-2032), Predicts DelveInsight | Key Players - Horizon Therapeutics, Dompe Farmaceutici, MorphoSys, Resolve Therapeutics, Novartis, Johnson & Johnson

33. Osteoarthritis Therapeutics Market to grow by USD 3.96 billion from 2022-2027, North America to account for 32% of market growth - Technavio

34. Allergy Immunotherapies Market to grow by USD 1.01 billion from 2022 to 2027; Europe to account for 53% of market growth - Technavio

35. Gene Therapy Global Market is Projected to Grow at a CAGR of ~19% by 2028, Predicts DelveInsight

36. Achondroplasia Treatment Drug Market to Register Positive Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Ascendis Pharma, QED Therapeutics (BridgeBio), Novartis, Sanofi, RIBOMIC

37. Contact Lens Solutions Market size to grow by USD 540.94 million from 2023 to 2028, Increased preference for contact lenses over spectacles to boost the market- Technavio

38. Castration-Resistant Prostate Cancer (CRPC) Treatment Market size to grow by USD 5.98 billion from 2023 to 2028, North America to account for 47% of market growth- Technavio

39. Active Pharmaceutical Ingredients Market is to grow by USD 86.47 billion from 2023 to 2028, Asia to account for 52% of market growth - Technavio

40. Cancer Immunotherapy Market to grow by USD 38.57 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio

41. Metastatic Castration-Resistant Prostate Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 7.5% During the Study Period (2019-2032), Estimates DelveInsight

42. Global Progressive Ataxia and Weakness Disorders Treatment Market Report: Focus on Key Players Novartis, Pfizer, Sanofi, GlaxoSmithKline, Roche, Merck, Takeda Pharmaceuticals and Abbott Laboratories

43. Global Melanoma Treatment Market Report 2023, Featuring Comprehensive Profiles of Leading Players including Amgen, Roche, Merck & Co., Pfizer Inc., BMS and Novartis

44. Global Melanoma Treatment Market Report 2023, Featuring Comprehensive Profiles of Leading Players including Amgen, Roche, Merck & Co., Pfizer Inc., BMS and Novartis

45. Alzheimer's Disease Therapeutics Market size to grow by USD 5.41 billion from 2023-2028; North America to account for 39% of market growth - Technavio

46. Global Tyrosine Kinase Inhibitors Market Report 2023-2028, Featuring Profiles of Major Players including Astrazeneca, Bayer, Bristol-Myers Squibb, Eisai, F. Hoffmann-La Roche, Novartis and Pfizer

47. Metastatic Castration-Sensitive Prostate Cancer Market to Skyrocket at Astounding 22% CAGR During the Study Period (2019-2032), assesses DelveInsight

48. The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight

49. The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight

50. Ewing's Sarcoma Treatment Market to grow by USD 205.09 million from 2024-2028; North America to account for 48% of market growth - Technavio

Catalog

Books, media, physical & digital resources